Clinical Trials on Allergic Bronchial Asthma in Canada

Total 4080 results

Aldeyra Therapeutics, Inc.

Completed

A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis

Allergic Conjunctivitis | Seasonal Allergies

Canada
Gail Gauvreau

Unknown

Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid Treatment (NACHO)

Allergic Asthma

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma

Asthma | Seasonal Allergic Rhinitis

Canada
Dr. Anne Ellis

Recruiting

The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy

Allergic Rhinitis | Peanut Allergies

Canada
Dr. Anne Ellis

Recruiting

Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS) (TEZARS)

Asthma With Allergic Rhinitis

Canada
Hamilton Health Sciences Corporation

Completed

Analysis of Fel d 1-specific T Cells After Airway Allergen Challenge in Asthma

Allergic Asthma

Canada
University of Saskatchewan

Completed

Tiotropium Efficacy Against Allergen Induced Early Asthmatic Responses

Allergic Asthma

Canada
University of Saskatchewan

Completed

Change in Airway Responsiveness After Allergen Exposure

Allergic Asthma

Canada
Desentum Oy

Completed

Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants

Birch Pollen Allergy

Canada
McMaster University
University of Saskatchewan

Not yet recruiting

Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma

Asthma, Allergic

Canada
Alexion

Completed

Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma

Allergic Asthma

Canada
AstraZeneca

Completed

A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma

Allergic Asthma

Canada
Hamilton Health Sciences Corporation
AstraZeneca

Completed

Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?

Mild Intermittent Asthma

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy

Ragweed Allergy

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma

Asthma | Seasonal Allergic Rhinitis

Canada
Asmacure Ltée

Completed

Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma

Mild Allergic Asthma

Canada
Novartis Pharmaceuticals

Completed

A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma

Allergic Asthma

Canada, Sweden
Cosmetique Active International
Innovaderm Research Inc.

Terminated

Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis

Asthma | Allergic Rhinitis | Eczema | Atopic Dermatitis | Food Allergies

United States, Canada
GlaxoSmithKline

Completed

To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies

Mild Asthma and Allergic Rhinitis

Canada
Bitop AG

Completed

The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo (PPL-003)

Allergic Rhinitis | Allergic Conjunctivitis

Canada
Probelte Pharma S.L.U.

Completed

Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander

Rhinoconjunctivitis With or Without Allergic Asthma

Spain
Laval University

Unknown

CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic Rhinitis

Asthma | Allergic Rhinitis

Canada
Laval University
AllerGen NCE Inc.

Completed

Nasal Allergen Challenge in Rhinitic Subjects

Asthma | Allergic Rhinitis

Canada
Genentech, Inc.

Completed

A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy (XPORT)

Allergic Asthma

United States
Novartis Pharmaceuticals
Genentech, Inc.

Completed

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists (eXplore)

Allergic Asthma

United States, Sweden, United Kingdom, France, Canada, Germany, Netherlands
University of British Columbia

Unknown

The Phthalate-Allergen Immune Response Study (PAIR)

Allergies

Canada
Laboratorios Leti, S.L.
Harrison Clinical Research

Terminated

Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma

Allergic Rhinitis | Mild Persistent Asthma | Rhinoconjunctivitis | Mild Intermittent Asthma

Spain
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber

Seasonal Allergic Rhinitis

Canada
University of British Columbia
Networks of Centres of Excellence of Canada; Allergy, Genes and Environment...

Completed

Genetics of the Early and Late Response to Allergen Challenge

Asthma | Allergic Rhinitis

Canada
University of British Columbia

Completed

Effects of Co-Exposure to Air Pollution and Allergen

Allergies

Canada
University of British Columbia

Completed

Air Pollution and Allergens - Attenuation of Health Effects Particle Reduction (DE3)

Allergies

Canada
Inmunotek S.L.

Recruiting

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

Rhinitis, Allergic | Rhinoconjunctivitis | Asthma, Allergic

Spain
PHAC/CIHR Influenza Research Network
University of Manitoba; University of British Columbia; CHU de Quebec-Universite... and other collaborators

Unknown

Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vaccine

Allergy | Anaphylaxis | Oculorespiratory Syndrome | Allergic-like Reactions

Canada
UCB Pharma

Completed

A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen

Rhinitis | Allergic | Seasonal

Canada
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Sanofi

Completed

Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants (FEXPOLSAR)

Rhinitis Seasonal

Canada
Novartis

Completed

A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber

Seasonal Allergic Rhinitis

Canada
MEDA Pharma GmbH & Co. KG

Completed

MP-AzeFlu Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
Gordon Sussman Clinical Research
Mast Cell Pharmaceuticals Inc.

Unknown

Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization

Peanut Allergies in Children

Canada
Ligand Pharmaceuticals

Completed

Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR

Seasonal Allergic Rhinitis

Canada
Ligand Pharmaceuticals

Completed

Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Sandoz

Terminated

Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies

Seasonal Allergic Rhinitis

Canada
Bayer
Queen's University

Completed

A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis (GEYSER)

Seasonal Allergic Rhinitis

Canada
Opella Healthcare Group SAS, a Sanofi Company

Completed

A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis (FEXPRESAR)

Seasonal Allergic Rhinitis

Canada
MEDA Pharma GmbH & Co. KG

Completed

Dymista Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
Glenmark Pharmaceuticals Ltd. India

Completed

Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301- PoC)

Seasonal Allergic Rhinitis

Canada
Allergy Therapeutics

Completed

Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis

Type I Hypersensitivity

Canada
MEDA Pharma GmbH & Co. KG

Completed

Azelastine Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
Altamira Medica Ltd.

Completed

Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers

Rhinitis, Allergic | Perennial Allergic Rhinitis

Canada

3

Subscribe